Oscar Health, Inc. plans to end its revolving credit facility, contingent on closing its offering of 2.25% Convertible Senior Subordinated Notes due 2030, as reported on September 16, 2025. This event is categorized under 'Changes in capital structure' and marks a significant shift for the company, depicted as neutral sentiment from an equity investor perspective.